News
Youngevity International, Inc Granted Motion for Summary Judgement Against Former President Dwayne Dundore
September 21, 2022
Florida Court Issues Order Awarding Youngevity Damages of $20,915,507 SAN DIEGO, CA —September 21, 2022 – Youngevity International, Inc. (OTCMRKTS: YGYI) (“Youngevity”) and its subsidiary Khrysos Industries, Inc today announced that the Circuit Court of
Categories: Business, Press Release
Youngevity International, Inc. Provides Update on Financial Reporting and Files Forms 10-Q for Quarters Ended March 31, June 30, and September 30, 2020
June 22, 2022
SAN DIEGO, Calif. —June 22, 2022 – Youngevity International, Inc. (OTCM: YGYI), (“YGYI” or the “Company”), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a direct marketing enterprise, and
Categories: Investor Relations, Letter, Press Release
Youngevity International, Inc. Announces Declaration of Monthly Dividend for May 2022 for Series “D” Cumulative Redeemable Perpetual Preferred Stock
May 20, 2022
SAN DIEGO, CA —May 20, 2022 – Youngevity International, Inc. (OTCM: YGYI), (“YGYI” or the “Company”), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred Stock (OTCM:YGYIP)
Categories: Investor Relations, Press Release
Youngevity International, Inc. Announces Declaration of Monthly Dividend for April 2022 for Series “D” Cumulative Redeemable Perpetual Preferred Stock
April 19, 2022
SAN DIEGO, CA —April 19, 2022 – Youngevity International, Inc. (OTCM: YGYI), (“YGYI” or the “Company”), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred
Categories: Investor Relations, Press Release
Youngevity International, Inc. Announces Declaration of Monthly Dividend for the 1st Quarter 2022 for Series “D” Cumulative Redeemable Perpetual Preferred Stock
January 14, 2022
SAN DIEGO, CA —January 14, 2022 – Youngevity International, Inc. (OTCM: YGYI), (“YGYI” or the “Company”), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred
Categories: Press Release, Investor Relations
Youngevity International, Inc. Announces Declaration of Monthly Dividend for the 4th Quarter 2021 for Series “D” Cumulative Redeemable Perpetual Preferred Stock
October 13, 2021
SAN DIEGO, CA – October 13, 2021 – Youngevity International, Inc. (OTCMKTS: : YGYI), (“YGYI” or the “Company”), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D
Categories: Press Release, Investor Relations
Youngevity International, Inc. Completes Restatement of its Previously Issued Quarterly Financial Statements for 2019. Audit Work Has Begun on 2020 Financial Results
September 14, 2021
Youngevity International, Inc. (OTCMKTS: : YGYI), a multi-channel lifestyle company operating in three distinct business segments, including a commercial coffee enterprise, a direct marketing enterprise, and a commercial hemp enterprise, today reported the completion of the
Categories: Press Release, Investor Relations
Youngevity International, Inc. Announces Declaration of Monthly Dividend for 3rd Quarter 2021 for Series “D” Cumulative Redeemable Perpetual Preferred Stock
July 15, 2021
SAN DIEGO, CA —July 15, 2021 – Youngevity International, Inc. (OTCM: YGYI), (“YGYI” or the “Company”), today announced the declaration of its regular monthly dividend of $0.203125 per share of its 9.75% Series D Cumulative Redeemable Perpetual Preferred
Categories: Press Release, Investor Relations
Youngevity International, Inc. Provides Update on Financial Reporting and Files Form 10-K for the Year Ended December 31, 2019
June 25, 2021
INCOME STATEMENT HIGHLIGHTS: Revenue for 2019 was $147.4 million compared to $162.4 million for 2018, a decrease of 9.2%. Gross profit decreased approximately $1.1 million for 2019 compared to 2018, a decrease of 1.1%. Adjusted EBITDA
Categories: Investor Relations, Press Release
2400 Boswell Road
Chula Vista, CA 91914
© 2008-2022 Youngevity International Corporation. All Rights Reserved
Type below to search
